Germline mutations in CDH1, the gene coding for the E-cadherin adhesion protein, are known to cause hereditary diffuse gastric cancer. We identified a new truncating germline mutation (p.Asp538Thrfs*19) in exon 11 of the CDH1 gene in a 41-year-old male with a diffuse gastric cancer. Although he had no parental history of gastric cancer, the co-segregation study in the family detected the same mutation in his healthy 31-year-old brother. The mutation affects one of the extracellular repeat (CAD repeats) domains which is essential for the homophilic binding specificity that directs “E-cadherin” to bind with itself each others. In this case, immunohistochemical analysis showed no expression of E-cadherin in the tumor sample and was a useful prescreening tool to genetic testing. This finding was associated with a poor response to trastuzumab-based treatment.

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach / Caggiari, L.; Miolo, G.; Canzonieri, V.; De Zorzi, M.; Alessandrini, L.; Corona, G.; Cannizzaro, R.; Santeufemia, D. A.; Cossu, A.; Buonadonna, A.; De Re, V.. - In: CANCER BIOLOGY & THERAPY. - ISSN 1538-4047. - 19:4(2018), pp. 254-259. [10.1080/15384047.2017.1394540]

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach

Cossu A.;
2018-01-01

Abstract

Germline mutations in CDH1, the gene coding for the E-cadherin adhesion protein, are known to cause hereditary diffuse gastric cancer. We identified a new truncating germline mutation (p.Asp538Thrfs*19) in exon 11 of the CDH1 gene in a 41-year-old male with a diffuse gastric cancer. Although he had no parental history of gastric cancer, the co-segregation study in the family detected the same mutation in his healthy 31-year-old brother. The mutation affects one of the extracellular repeat (CAD repeats) domains which is essential for the homophilic binding specificity that directs “E-cadherin” to bind with itself each others. In this case, immunohistochemical analysis showed no expression of E-cadherin in the tumor sample and was a useful prescreening tool to genetic testing. This finding was associated with a poor response to trastuzumab-based treatment.
2018
A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach / Caggiari, L.; Miolo, G.; Canzonieri, V.; De Zorzi, M.; Alessandrini, L.; Corona, G.; Cannizzaro, R.; Santeufemia, D. A.; Cossu, A.; Buonadonna, A.; De Re, V.. - In: CANCER BIOLOGY & THERAPY. - ISSN 1538-4047. - 19:4(2018), pp. 254-259. [10.1080/15384047.2017.1394540]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/241190
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact